These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34094691)

  • 1. Trends in treatments for prostate cancer in the United States, 2010-2015.
    Wang J; Xia HH; Zhang Y; Zhang L
    Am J Cancer Res; 2021; 11(5):2351-2368. PubMed ID: 34094691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US.
    Washington SL; Jeong CW; Lonergan PE; Herlemann A; Gomez SL; Carroll PR; Cooperberg MR
    JAMA Netw Open; 2020 Dec; 3(12):e2031349. PubMed ID: 33369661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015.
    Butler SS; Loeb S; Cole AP; Zaslowe-Dude C; Muralidhar V; Kim DW; Schaeffer EM; Trinh QD; Nguyen PL; Mahal BA
    Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):179-183. PubMed ID: 31591454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations.
    Jeong CW; Washington SL; Herlemann A; Gomez SL; Carroll PR; Cooperberg MR
    Eur Urol; 2020 Sep; 78(3):335-344. PubMed ID: 31980309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing trends and disparities in 5-year overall survival of women with invasive breast cancer in the United States, 1975-2015.
    Yang M; Hu X; Bao W; Zhang X; Lin Y; Stanton S; Haffty B; Hu W; Kang Y; Wei S; Zhang L
    Am J Cancer Res; 2021; 11(6):3201-3211. PubMed ID: 34249455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Surveillance for Men with Intermediate Risk Prostate Cancer.
    Agrawal V; Ma X; Hu JC; Barbieri CE; Nagar H
    J Urol; 2021 Jan; 205(1):115-121. PubMed ID: 32658588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable-risk prostate cancer.
    Huang D; Ruan X; Huang J; Zhang N; Jiang G; Gao Y; Xu D; Na R
    Cancer Med; 2023 Apr; 12(8):9868-9878. PubMed ID: 36727535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-Based Assessment of Determining Treatments for Prostate Cancer.
    Chamie K; Williams SB; Hu JC
    JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).
    Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E
    BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score.
    Herget KA; Patel DP; Hanson HA; Sweeney C; Lowrance WT
    Cancer Med; 2016 Jan; 5(1):136-41. PubMed ID: 26628287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer.
    Butler SS; Mahal BA; Lamba N; Mossanen M; Martin NE; Mouw KW; Nguyen PL; Muralidhar V
    Cancer; 2019 Sep; 125(18):3164-3171. PubMed ID: 31150125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
    Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D
    Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database.
    Mahal AR; Butler S; Franco I; Muralidhar V; Larios D; Pike LRG; Zhao SG; Sanford NN; Dess RT; Feng FY; D'Amico AV; Spratt DE; Yu JB; Nguyen PL; Rebbeck TR; Mahal BA
    Cancer; 2019 Oct; 125(19):3338-3346. PubMed ID: 31251398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer.
    Gray PJ; Lin CC; Cooperberg MR; Jemal A; Efstathiou JA
    Eur Urol; 2017 May; 71(5):729-737. PubMed ID: 27597241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
    Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
    J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of survival between active surveillance or watchful waiting and focal therapy for low-risk prostate cancer: a real-world study from the SEER database.
    Yuan QM; Lin TH; Jin K; Qiu S; Zhou XH; Jin D; Li JK; Yang L; Wei Q
    Asian J Androl; 2022; 24(3):305-310. PubMed ID: 34596600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity, 2000-2017.
    Cao Y; Zhang W; Li Y; Fu J; Li H; Li X; Gao X; Zhang K; Liu S
    Prostate; 2021 Oct; 81(14):1071-1077. PubMed ID: 34320230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):184-90. PubMed ID: 23271771
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.